Reaction Details Report a problem with these data
Target
Vascular endothelial growth factor A
Ligand
BDBM126621
Substrate
n/a
Meas. Tech.
ELISA Assay
IC50
53000±n/a nM
Citation
 Gardner, JH; Shalwitz, R; Wu, S Prolyl hydroxylase inhibitors US Patent  US10562854 Publication Date 2/18/2020 
Target
Name:
Vascular endothelial growth factor A
Synonyms:
VEGF | VEGF-A | VEGFA | VEGFA_HUMAN | VPF | Vascular endothelial growth factor (VEGF) | Vascular endothelial growth factor A (VEGF) | Vascular endothelial growth factor A (VEGF2) | Vascular permeability factor
Type:
Protein
Mol. Mass.:
27063.81
Organism:
Homo sapiens (Human)
Description:
P15692
Residue:
232
Sequence:
MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR
  
Inhibitor
Name:
BDBM126621
Synonyms:
US10562854, No. B5 | US8778412, B5 | US9278930, B5
Type:
Small organic molecule
Emp. Form.:
C19H24N2O3
Mol. Mass.:
328.4055
SMILES:
OCC[C@H]1CCCN1Cc1ccn(Cc2ccccc2)c(=O)c1O |r|
Structure:
Search PDB for entries with ligand similarity: